Picture of Citrine Global logo

CTGL Citrine Global Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Citrine Global, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-8.64-4.52-2.65-3.1-2.3
Depreciation
Non-Cash Items7.721.641.431.831.28
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.222.290.6481.071.01
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.696-0.582-0.567-0.199-0.004
Capital Expenditures-0.006-0.252-0.0040
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.6090.5380.0150
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.6150.2860.0110
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.50.350.360.13-0.002
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.1890.074-0.203-0.07-0.006